Abstract
Summary: Acute encephalopathic crisis in glutaryl-CoA dehydrogenase deficiency results in an unfavourable disease course and poor outcome, dominated by dystonia, feeding problems, seizures and secondary complications, and quite often leading to early death. The prerequisite for the prevention of irreversible brain damage in this disease is the detection of affected patients and initiation of treatment before the manifestation of such crisis. Apart from macrocephaly there are no signs or symptoms characteristic for this disease in presymptomatic children and, thus, they are usually missed. In some countries, implementation of extended neonatal screening programmes using electrospray ionization tandem mass spectrometry (ESI-MS/MS) allows detection of affected newborns and start of therapy before onset of neurological complications. This article summarizes recent strategies, pitfalls and shortcomings of a mass screening for glutaryl-CoA dehydrogenase deficiency using ESI-MS/MS. Furthermore, an alternative strategy, namely DNA-based neonatal screening for the Oji-Cree variant of this disease, is demonstrated. An optimization of diagnostic as well as therapeutic procedures must be achieved before GCDH deficiency unequivocally fullfils the criteria of a reliable and successful newborn screening programme.
Similar content being viewed by others
REFERENCES
Baric I, Wagner L, Buckel W, Hoffmann GF (1999)Sensitivity of free and total glutaric and 3-hydroxyglutaric acid measurement by stable isotope dilution assays for the diagnosis of glutaric aciduria type I.JInheritMetabDis 22:867-882.
Busquets C, Merinero B, Christensen E, et al (2000)Glutaryl-CoA dehydrogenase de ficiency in Spain:evidence of two groups of patients,genetically,and biochemically distinct.Pediatr Res 48:315-322.
Chace DH, Kalas TA, Naylor EW (2002)The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism.Annu Rev Genomics Hum Genet 3:17-45.
Chace DH, Kalas TA, Naylor EW (2003)Use of tandem mass spectrometry for multi-analyte screening of dried blood specimens from newborns.Clin Chem 49:1797-1817.
Greenberg CR, Prasad AN, Dilling LA, et al (2002)Outcome of the first three years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and Northwestern Ontario,Canada.Mol Gen Metab 75:70-78.
Hoffmann GF, Athanassopoulos A, Burlina A, et al (1996)Clinical course,early diagnosis, treatment and prevention of disease in glutaryl-CoA dehydrogenase de ficiency. Neuropediatrics 27:115-123.
Kölker S, Greenberg CR, Lindner M, Mffller E, Naughten ER, GF Hoffmann (2004a)Emergency treatment in g utary-CoA dehydrogenase defficiency.J Inherit Metab Dis 27:893-902.
Kölker S, Burgard P, Okun JG, et al (2004b)Looking forward an evidence-based approach to glutaryl-CoA dehydrogenase de ficiency.J Inherit Metab Dis 27:921-926.
Múhlhausen C, Hoffmann GF, Strauss KA, et al (2004)Maintenance treatment of glutaryl-CoA dehydrogenase de ficiency.JInheritMetabDis 27:885-892.
Naylor EW, Chace DW (1999)Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid,organic cid,and amino acid metabolism.J Child Neurol 14 (Supplement 1):S48.
Roscher AA, Fingerhut R, Liebl B, Olgemöller B (2001)Erweiterung des Neugeborenen screenings durch Tandemmassenspektrometrie.Monatsschr Kinderheilk 149:1297-1303.
Schulze A, Lindner M, Kohlmúller D, Olgemöller K, Mayatepek E, Hoffmann GF (2003)Expanded newborn screening for inborn errors of metabolism by electrospray ionization tandem mass spectrometry:results,outcome,and implications.Pediatrics 111:1399-1406.
Smith WE, Millington DS, Koeberl DK, Lesser PS (2001)Glutaric acidemia,type I,missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics 107:1184-1187.
Superti-Furga A (2004)Glutaric aciduria type 1 and neonatal screening:time to proceed with caution.Eur J Pediatr 162:S17-S20.
Wilcken B, Wiley V, Hammond J, Carpenter K (2003)Screening newborns for inborn errors of metabolism by tandem mass spectrometry.NEngl JMe 348:2304 2312.
Wiley V, Carpenter K, Wilcken B (1999)Newborn screening with tandem mass spectrometry: 12 months 'experience in NSW Australia.Acta Paediatr Suppl 88:48 51.
Zschocke J, Baric I, Merinero B, et al (1997)Wertigkeit der Acylcarnitinanalyse fffr die Diagnose der Glutarazidurie Typ I.Monatsschr Kinderheilk 145:432.
Zytkovicz TH, Fitzgerald EF, Marsden D, et al (2001)Tandem mass spectrometric analysis for amino,organic,and fatty acid disorders in newborn dried blood spots:a two-year summary from the New England Newborn Screening Program.Clin Chem 47:1945-1955.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lindner, M., KÖlker, S., Schulze, A. et al. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27, 851–859 (2004). https://doi.org/10.1023/B:BOLI.0000045769.96657.af
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000045769.96657.af